Our findings confirm the upregulation of RHOA following miR-512 inhibition in MMD ECFCs, implicating ARHGEF3 in angiogenesis and RHOA/RHO-associated coiled-coil kinase (ROCK) signaling47,48. Here, ARHGEF3 is linked to multiminicore myopathy.